

Drugmakers Boost Capacity for Weight Loss Drugs
Feb 14, 2024
The podcast discusses the partnership between Novo Nordisk and CATALENT in the pharmaceutical industry, specifically their efforts to increase capacity for weight loss drugs and concerns about long-term risks of these drugs.
Chapters
Transcript
Episode notes